NO982107D0 - Fremstilling av et salt av klavulansyre - Google Patents

Fremstilling av et salt av klavulansyre

Info

Publication number
NO982107D0
NO982107D0 NO982107A NO982107A NO982107D0 NO 982107 D0 NO982107 D0 NO 982107D0 NO 982107 A NO982107 A NO 982107A NO 982107 A NO982107 A NO 982107A NO 982107 D0 NO982107 D0 NO 982107D0
Authority
NO
Norway
Prior art keywords
clavulanic acid
pct
butanol
salt
date
Prior art date
Application number
NO982107A
Other languages
English (en)
Norwegian (no)
Other versions
NO982107L (no
Inventor
Helmut Wagner
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of NO982107L publication Critical patent/NO982107L/no
Publication of NO982107D0 publication Critical patent/NO982107D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/02—Preparation
    • C07D503/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D503/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
NO982107A 1995-11-15 1998-05-08 Fremstilling av et salt av klavulansyre NO982107D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0186795A AT403375B (de) 1995-11-15 1995-11-15 Verfahren zur fällung von alkalisalzen der clavulansäure
PCT/EP1996/005015 WO1997018216A1 (en) 1995-11-15 1996-11-14 Production of a salt of clavulanic acid

Publications (2)

Publication Number Publication Date
NO982107L NO982107L (no) 1998-05-08
NO982107D0 true NO982107D0 (no) 1998-05-08

Family

ID=3522721

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982107A NO982107D0 (no) 1995-11-15 1998-05-08 Fremstilling av et salt av klavulansyre

Country Status (24)

Country Link
US (1) US6133441A (pl)
EP (1) EP0874855B1 (pl)
JP (1) JP4319252B2 (pl)
KR (1) KR100537732B1 (pl)
CN (1) CN1090636C (pl)
AT (2) AT403375B (pl)
AU (1) AU714017B2 (pl)
BR (1) BR9611572A (pl)
CA (1) CA2237763C (pl)
CZ (1) CZ296567B6 (pl)
DE (1) DE69631608T2 (pl)
ES (1) ES2216073T3 (pl)
HU (1) HUP9903478A3 (pl)
IL (1) IL124353A (pl)
MX (1) MX9803887A (pl)
NO (1) NO982107D0 (pl)
NZ (1) NZ322485A (pl)
PL (1) PL188634B1 (pl)
RU (1) RU2179171C2 (pl)
SI (1) SI0874855T1 (pl)
SK (1) SK285138B6 (pl)
TR (1) TR199800860T2 (pl)
TW (1) TW427991B (pl)
WO (1) WO1997018216A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
ATE286057T1 (de) * 2000-10-20 2005-01-15 Sandoz Ag Pharmazeutische zubereitungen enthaltend clavulansäure
WO2009049086A1 (en) 2007-10-09 2009-04-16 Larry Sutton Broad spectrum beta-lactamase inhibitors
WO2010118361A1 (en) * 2009-04-09 2010-10-14 Sopharmia, Inc. Beta lactamase inhibitors
JP6403289B2 (ja) 2013-03-12 2018-10-10 グラディウス ファーマシューティカルズ コーポレーションＧｌａｄｉｕｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐｏｒａｔｉｏｎ 誘導体化３−スチリル−セファロスポリン
CN109535184B (zh) * 2017-09-21 2020-11-20 联邦制药(内蒙古)有限公司 一种克拉维酸叔辛胺制备克拉维酸钾的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
US4144242A (en) * 1975-02-07 1979-03-13 Glaxo Laboratories Limited Process for the purification of clavulanic acid
GB2003863B (en) * 1977-09-01 1982-03-31 Beecham Group Ltd Chemical process
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
AU600655B2 (en) * 1984-10-27 1990-08-23 Beecham Group Plc Preparation of clavulanic acid and its salts and esters
GB8618888D0 (en) * 1986-08-01 1986-09-10 Davy Mckee Ltd Process
GB2200355B (en) * 1987-01-29 1990-08-01 Beecham Group Plc Potassium clavulanate
US5679789A (en) * 1987-01-29 1997-10-21 Beecham Group, P.L.C. Pharmaceutical compositions comprising potassium clavulanate and methods of using them
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
US5210296A (en) * 1990-11-19 1993-05-11 E. I. Du Pont De Nemours And Company Recovery of lactate esters and lactic acid from fermentation broth
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB2298201B (en) * 1995-02-25 1997-05-28 Spurcourt Ltd Clavulanic acid salts
CZ266697A3 (en) * 1995-02-25 1997-11-12 Spurcourt Ltd Salts of clavulanic acid
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl) * 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
SI9500265A1 (en) * 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
US6414142B1 (en) * 1996-06-13 2002-07-02 Smithkline Beecham Corporation Process for preparing potassium clavulanate
WO1998021212A1 (en) * 1996-11-11 1998-05-22 Gist-Brocades B.V. Process for the preparation of salts and esters of clavulanic acid

Also Published As

Publication number Publication date
IL124353A (en) 2005-06-19
ATE259817T1 (de) 2004-03-15
BR9611572A (pt) 1999-03-30
ES2216073T3 (es) 2004-10-16
RU2179171C2 (ru) 2002-02-10
TR199800860T2 (xx) 2000-07-21
ATA186795A (de) 1997-06-15
PL326696A1 (en) 1998-10-26
CZ149198A3 (cs) 1998-08-12
HK1016971A1 (en) 1999-11-12
EP0874855B1 (en) 2004-02-18
AU7625096A (en) 1997-06-05
EP0874855A1 (en) 1998-11-04
NZ322485A (en) 2000-01-28
TW427991B (en) 2001-04-01
CN1090636C (zh) 2002-09-11
NO982107L (no) 1998-05-08
AT403375B (de) 1998-01-26
AU714017B2 (en) 1999-12-16
US6133441A (en) 2000-10-17
PL188634B1 (pl) 2005-03-31
CA2237763C (en) 2008-05-06
DE69631608T2 (de) 2004-12-23
DE69631608D1 (de) 2004-03-25
HUP9903478A2 (hu) 2000-03-28
KR100537732B1 (ko) 2006-04-14
JP2000500149A (ja) 2000-01-11
SK64098A3 (en) 1998-10-07
CA2237763A1 (en) 1997-05-22
SI0874855T1 (en) 2004-06-30
HUP9903478A3 (en) 2000-05-29
CN1204337A (zh) 1999-01-06
CZ296567B6 (cs) 2006-04-12
SK285138B6 (sk) 2006-07-07
JP4319252B2 (ja) 2009-08-26
KR19990067480A (ko) 1999-08-25
MX9803887A (es) 1998-09-30
IL124353A0 (en) 1998-12-06
WO1997018216A1 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
HUT77372A (hu) Új benzil-pirimidinek, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
DE59402222D1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
ATE202337T1 (de) Cyclopropylalkansäurederivate
NO982606D0 (no) Naftylsubstituerte benzimidazolderivater som antikoagulanter
DE69332259D1 (de) Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
BR9507231A (pt) Uso de derivados de ácido carboxílico para a produção de drogas
NO982107L (no) Fremstilling av et salt av klavulansyre
ATE19870T1 (de) 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
ATE36854T1 (de) Tetrahydrothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ES2133414T3 (es) Derivados de amida.
DE3269029D1 (en) Bis-hydroxymethyl carbonate bridged antibacterial agents
DK0871632T3 (da) Produktion af et krystallinsk salt af amoxycillin
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
ATE80629T1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln.
ES476259A1 (es) Un procedimiento para la preparacion de un compuesto.
JPS5430165A (en) 2-allylamino-5-phenyloxazoles and their pharmaceutically acceptable aicd salts

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application